Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Osteosarcoma, Tongue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Intraocular Lymphoma

NCT03672305 2018-09-18

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

Phase EARLY_PHASE1 Unknown

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT01247298 2017-08-21

RAD 0902

Phase EARLY_PHASE1 Completed

17 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01968629 2015-09-23

24hr Imaging Of HCC After EOVIST

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT00436410 2012-05-02

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Phase EARLY_PHASE1 Completed

108 enrolled

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Fibrosarcoma, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Colorectal Neoplasms, Adrenocortical Carcinoma, Breast Neoplasms, Male

NCT01337492 2012-03-21

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

Phase EARLY_PHASE1 Terminated

2 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT00884520 2010-03-16

VM4-037

Phase EARLY_PHASE1 Completed

16 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Hypoxia, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms

Clinical Trials

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

Wondercel-UWD3

NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma

A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

SN301A

Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio

Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)

Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)

YYFZJDTRHCLT3D

Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC

VEROnA

Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma

ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma

Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

YYFZTIHBVHCC

ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer

Effectiveness of Drug Eluting TACE in Primary HCC

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

RAD 0902

24hr Imaging Of HCC After EOVIST

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

VM4-037